Identification of genes highly downregulated in pancreatic cancer through a meta-analysis of microarray datasets: implications for discovery of novel tumor-suppressor genes and therapeutic targets

Journal of Cancer Research and Clinical Oncology
Nalin C W GoonesekereXiaosheng Wang

Abstract

The lack of specific symptoms at early tumor stages, together with a high biological aggressiveness of the tumor contribute to the high mortality rate for pancreatic cancer (PC), which has a 5-year survival rate of about 7%. Recent failures of targeted therapies inhibiting kinase activity in clinical trials have highlighted the need for new approaches towards combating this deadly disease. In this study, we have identified genes that are significantly downregulated in PC, through a meta-analysis of large number of microarray datasets. We have used qRT-PCR to confirm the downregulation of selected genes in a panel of PC cell lines. This study has yielded several novel candidate tumor-suppressor genes (TSGs) including GNMT, CEL, PLA2G1B and SERPINI2. We highlight the role of GNMT, a methyl transferase associated with the methylation potential of the cell, and CEL, a lipase, as potential therapeutic targets. We have uncovered genetic links to risk factors associated with PC such as smoking and obesity. Genes important for patient survival and prognosis are also discussed, and we confirm the dysregulation of metabolic pathways previously observed in PC. While many of the genes downregulated in our dataset are associated with protei...Continue Reading

References

Sep 29, 2001·The New England Journal of Medicine·S S FajansK S Polonsky
Apr 8, 2004·Neoplasia : an International Journal for Oncology Research·Daniel R RhodesArul M Chinnaiyan
Apr 23, 2005·Nature Methods·Rafael A IrizarryWayne Yu
Sep 27, 2005·PLoS Genetics·Stacie K LoftusWilliam J Pavan
Oct 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Aravind SubramanianJill P Mesirov
Dec 31, 2005·Nucleic Acids Research·Chris StarkMike Tyers
Sep 22, 2006·Biochimica Et Biophysica Acta·Ferdinando ChiaradonnaLilia Alberghina
Dec 28, 2006·BMC Medicine·Paolo P ProvenzanoPatricia J Keely
Jan 5, 2007·BMC Cancer·Rosalyn D BlumenthalDavid M Goldenberg
Mar 16, 2007·Neoplasia : an International Journal for Oncology Research·Daniel R RhodesArul M Chinnaiyan
Aug 7, 2007·Seminars in Oncology·Suresh T Chari
Mar 6, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M Luz Martínez-ChantarJosé M Mato
Sep 5, 2008·PLoS Medicine·Adaikalavan RamasamyDouglas G Altman
Dec 30, 2008·The Lancet Oncology·Rahul PannalaSuresh T Chari
Jun 2, 2009·The Journal of Biological Chemistry·Zigmund LukaConrad Wagner
Jul 25, 2009·Surgery·Nicholas J ZyromskiHarikrishna Nakshatri
Sep 17, 2009·Molecular Systems Biology·Joel T DudleyAtul J Butte
Oct 15, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard L PiekarzSusan E Bates
Dec 4, 2009·Applied Immunohistochemistry & Molecular Morphology : AIMM·Richa JainRunjan Chetty
Apr 30, 2010·The New England Journal of Medicine·Manuel Hidalgo
Aug 10, 2010·BMC Research Notes·Emma Laing, Colin P Smith
Oct 29, 2010·Nature·Shinichi YachidaChristine A Iacobuzio-Donahue
Aug 13, 2011·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Mariko TanakaMasashi Fukayama
Sep 29, 2011·Journal of Cancer Research and Clinical Oncology·Hongfei JiangSongying Zhang
Dec 1, 2011·Pathology International·Suguru YonezawaMasamichi Goto
Mar 28, 2012·Cancer Letters·Shinichi Fukushige, Akira Horii
Mar 30, 2013·Science·Bert VogelsteinKenneth W Kinzler
Apr 30, 2013·Gastroenterology·Minoti V ApteStephen J Pandol
Jul 23, 2013·Nature Protocols·Huaiyu MiPaul D Thomas
Aug 7, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Geng ZhangS Perwez Hussain
Oct 12, 2013·Nature Communications·Kosuke YoshiharaRoel G W Verhaak
Nov 1, 2013·Human Genomics·Claire HeitVasilis Vasiliou
Mar 7, 2014·Frontiers in Physiology·Frank U Weiss
Mar 19, 2014·Laboratory Investigation; a Journal of Technical Methods and Pathology·Kelly R PekalaMaureen A Gannon
Jan 6, 2015·Cancer·Luc G T Morris, Timothy A Chan
Jan 28, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marco Dal MolinLaura D Wood

❮ Previous
Next ❯

Citations

Aug 3, 2018·Medical & Biological Engineering & Computing·Manosij GhoshRam Sarkar
Jun 28, 2020·Scientific Reports·Charu KothariFrancine Durocher
Feb 23, 2019·Chemico-biological Interactions·Sergey A Krupenko, Natalia I Krupenko
Apr 4, 2021·Pharmaceuticals·Zachary HeinzmanNalin C W Goonesekere
Apr 5, 2021·Biochemical Genetics·Ehsan SohrabiYousef Sefidi-Heris

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.